A University of Pittsburgh study inspired by the late Freddie H. Fu, MD, one of the world's leading orthopedic surgeons, is ...

This Research Topic centers on the ongoing impacts of COVID-19, particularly focusing on the Post-Acute Sequelae of ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that disproportionately affects women and people of color. It begins in adolescence and can be debilitating, negatively impacting ...

Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after Only ...

The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer ...

Across the last 3 decades, worldwide age-standardized stroke burden rates have declined although some areas have seen increases in disability-adjusted life year rates and age-standardized prevalence, ...

Improvements Across Measures of Behavior, Function, Cognition and Movement -- Expediting Plans to Advance CT1812 into Late-Stage Trials -- Full ...

Additionally, results from preclinical studies provide proof-of-mechanism for recovery of muscle function with ClC-1 inhibition using NMD670 in CMT mouse models Aarhus, Denmark, 18 December 2024 – NMD ...

Physicians at the University of Oklahoma Health Sciences are leading a national clinical trial over an investigational device ...

NHS England has launched a review of digital clinical safety standards, requesting input from NHS stakeholders and IT manufacturers.